Skip to main content
. 2006 Sep 18;50(11):3939–3943. doi: 10.1128/AAC.00503-06

TABLE 1.

Study subjectsa

Subject no. Sample no. Sample day MIC(s) (μg/ml) Mutation(s) in:
OSTd PFGE pattern(s)
gyrA parC
1 1 0 70.25 A87T None Neg A
2 28 0.25 A87T None Pos A
3 41 Neg
4 57 Neg
5
6
7
8
9
10
2 1 0 0.5 S83L Neg Neg B
2 58 Neg
3 71 Neg
4 85 Neg
5 99 Neg
6 119 Neg
7 176 Neg
8
9
10
3 1 0 32 S83L, D87G S80I Pos C
2 17 Neg
3 28 Neg
4 44 Neg
5 57 32 S83L, D87G S80I Pos C
6 71 Neg
7 85 32 S83L, D87G S80I C
8 100 Neg
9 128 0.064 Neg Neg Pos D
10 156 Neg
4 1 0 0.19 Neg Neg Neg E
2 17 Neg
3 35 Neg
4 45 Neg
5 60 Neg
6 72 Neg
7 92 Neg
8 102 0.064 Neg Neg Neg E
9 140 Neg
10 178 Neg
5 1 0 >32 S83L, D87T S83L, D87T Pos F
2 17 >32 S83L, D87T S83L, D87T Pos F
3 29 >32 S83L, D87T S83L, D87T Pos F
4 38 >32 S83L, D87T S83L, D87T Pos F
5 58 >32 S83L, D87T S83L, D87T Pos F
6 71 >32 S83L, D87T S83L, D87T Pos F
7 85 >32 S83L, D87T S83L, D87T Pos F
8 112 >32 S83L, D87T S83L, D87T Pos F
9 139 >32 S83L, D87T S83L, D87T Pos F
10 167 >32 S83L, D87T S83L, D87T Pos F
6 1 0 32 S83L, D87D S80I, G84V Pos NT
2 12 32 S83L, D87D S80I, G84V Pos NT
3 27 32/32b S83L, D87D S80I, G84V Neg/neg NT
4 41 32 S83L, D87D S80I, G84V Pos NT
5 56 32 S83L, D87D S80I, G84V Neg NT
6 70 Neg
7 83 32 S83L, D87D S80I, G84V Pos NT
8 134 Neg
9 153 32 S83L, D87D S80I, G84V Pos NT
10
gyrA parC
7 1 0 0.25 D87T Neg Neg G
2 12 0.25 D87T Neg Neg G
3 26 Neg
4 41 Neg
5 56 Neg
6 70 0.25 D87T Neg Neg G
7 84 0.25 D87T Neg Neg G
8 106 0.38 D87T Neg Neg G
9 132 NA NA NA NA NA
10 162 0.19 D87T Neg Neg G
8 1 0 0.19 Neg Neg Pos H
2 28 Neg
3 37 0.38 Neg Neg Pos H
4 51 0.25 Neg Neg Pos H
5 65 0.125 Neg Neg Pos H
6 79 0.125 Neg Neg Pos H
7 94 0.19 Neg Neg Pos H
8 107 0.19 Neg Neg Pos H
9 141 Neg
10 177 Neg
9 1 0 >32 S83L, D87N S80I Pos I
2 21 >32 S83L, D87N S80I Pos I
3 34 0.5 S83L Neg Neg J
4 50 0.5 S83L Neg Neg J
5 64 >32/0.5c S83L, A87Nc S80Ic Pos/negc I/J
6 92 >32 S83L, D87N S80I Pos I
7 99 0.5 S83L Neg Neg J
8 112 0.19 S83L Neg Neg J
9 146 >32 S83L, D87N S80I Pos I
10 173 >32 S83L, D87N Neg Pos I
10 1 0 0.38 D87N Neg Neg K
2 38 0.38 D87N Neg Neg K
3 53 0.38 D87N Neg Neg K
4 66 0.38 D87N Neg Neg NA
5 80 0.38 D87N Neg Neg K
6 95 0.25 D87N Neg Neg K
7 127 0.10 D87N Neg Neg K
8 148 Neg
9
10
a

Sample no. 1 represents the final inpatient sample; sample day refers to the number of days after discharge the sample was obtained. There was no genetic relatedness of isolates across subjects. Neg, negative; Pos, positive; NA, not available; NT, not typeable.

b

Two strains identified differed only in that one strain had the noted parC mutations while the other strain had no parC mutations.

c

The MIC values, gyrA and parC mutations, and the OST findings were consistent with both previously identified strains in this patient.

d

OST, organic-solvent tolerance.